TheEdgeResearch
Home / Stocks / NVACF

Nova Cannabis Inc. (NVACF)

OTC Healthcare Medical - Pharmaceuticals
$1.26 ▼ -2.77%
Market Cap
$78.5M
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-2.06
52-Wk Range
1.25-1.308
CEO
Grant Sanderson
Country
CA
Currency
USD

Nova Cannabis Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Edmonton, AB, CA. The stock last traded at $1.26, down 2.77% on the session, giving a market capitalisation of $78.5M. On trailing twelve-month figures it carries a trailing P/E of 32.89, a net margin of 1.2%. Its beta of -2.06 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
32.89
Price / Sales
0.42
Price / Book
1.96
EV / EBITDA
8.31
Gross margin
19.4%
Operating margin
3.8%
Net margin
1.2%
Return on equity
Debt / equity
1.26
Current ratio
1.22
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
719
IPO date
2021-03-24
Headquarters
Edmonton, AB, CA
About Nova Cannabis Inc.

Nova Cannabis Inc. runs a chain of retail cannabis stores throughout Canada, primarily catering to the recreational adult-use market. As of March 31, 2022, the company managed 78 such locations across Alberta, Ontario, and Saskatchewan. The firm's headquarters are situated in Edmonton, Canada, and Nova Cannabis Inc. is a division of Alcanna Inc.

Comparable companies

Nova Cannabis Inc. is most often compared with the following Healthcare names:

BIOGFCKMTFEOFBYETXPFKIARFLFLYMCURFRSHUFRTGNTIHE
More research on NVACF
NVACF technical analysis NVACF TheEdge Score Compare against peers
Open full interactive analysis & DCF →